Viz AAA vs KardiaAI

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Viz AAA

by Viz.ai

KardiaAI

by AliveCor

AI Verdict

Viz AAA is an AI solution focused on the detection and triage of suspected Abdominal Aortic Aneurysm from CT angiography scans, streamlining care for a specific structural condition. In contrast, KardiaAI is an AI software library for analyzing ambulatory ECG rhythms to detect various cardiac electrical conditions. While both utilize AI in cardiology and emergency medicine, they address distinct diagnostic challenges using different input modalities and target different aspects of cardiac health.

Choose Viz AAA if…

Choose Viz AAA if your primary need is rapid, AI-powered detection and triage of suspected Abdominal Aortic Aneurysm (AAA) directly from CT angiography scans within an acute care hospital setting. This tool is ideal for accelerating diagnosis, streamlining care coordination among multidisciplinary teams, and enabling quick treatment decisions for critical vascular conditions.

View Viz AAA →

Choose KardiaAI if…

Choose KardiaAI if you require a robust, FDA-cleared AI software library for comprehensive analysis of ambulatory ECG rhythms to detect a wide range of cardiac conditions like AFib, bradycardia, and tachycardia. This solution is best suited for integration into existing ECG devices, mobile apps, or web platforms to provide medical-grade heart rhythm data analysis for ongoing monitoring or point-of-care screening.

View KardiaAI →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Viz AAA	KardiaAI
Pricing	Subscription model	Subscription-based for advanced features and services.
Deployment	Cloud-based	Mobile app, cloud-based.
BAA Available	Yes AI-estimated	Yes AI-estimated
FDA Status	Cleared AI-estimated	Cleared AI-estimated
HIPAA	Yes AI-estimated	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Viz AAA

Viz AAA is designed for seamless integration into existing hospital workflows, offering real-time alerts, a HIPAA-compliant communication platform, and mobile access to imaging for multidisciplinary teams. It has been rated #1 in 'Ease of Implementation & Adoption' and 'User Satisfaction & Acceptance' in a Black Book survey, indicating high clinician satisfaction within its complex enterprise environment.

Clinical Value

Viz AAA

Both tools are FDA-cleared and clinically validated. Viz AAA focuses on accelerating diagnosis and care coordination for acute, life-threatening conditions like Abdominal Aortic Aneurysm (AAA) and stroke, with studies demonstrating high sensitivity and specificity and a positive impact on time-to-treatment and patient outcomes. While KardiaAI offers broad and accurate arrhythmia detection, Viz AAA's impact on time-critical interventions for conditions with immediate life-threatening potential gives it a slight edge in acute clinical impact.

Pricing & Value

KardiaAI

KardiaAI offers clear, publicly available subscription pricing for its direct-to-consumer services, providing transparency and accessibility for individual users. While Viz AAA's pricing is a customized subscription model for hospitals and not publicly disclosed, KardiaAI's transparent pricing for its core services makes its value proposition more readily understandable.

Enterprise Readiness

Viz AAA

Viz AAA is a comprehensive, cloud-based solution explicitly designed for hospital systems, with deep integration into existing EHR and PACS workflows, real-time alerts, and a communication platform. It boasts widespread adoption across nearly 2,000 hospitals and high ratings for implementation ease, customization, and multi-vendor compatibility. KardiaAI, while offering robust API/SDK integrations and EHR compatibility, functions more as an enabling component rather than a complete, standalone enterprise solution.

Innovation

Viz AAA

Viz AAA holds the distinction of being the 'first FDA-cleared AI-powered solution' for AAA detection and triage from CT angiography scans, marking a significant breakthrough in a specialized and critical area. Additionally, Viz.ai recently launched Viz Agent Studio, the 'first agentic platform' enabling health systems to build and deploy customizable AI care pathways, demonstrating innovation beyond just disease detection.

Support & Docs

Viz AAA

Viz AAA provides a comprehensive support structure, including dedicated 24/7 on-call specialists, implementation experts, and a customer success team. This robust support is validated by its #1 ranking in 'Vendor Responsiveness & Technical Support' in a Black Book survey. While KardiaAI offers customer service and engineering support for partners, the level of detail and external validation for its support infrastructure is less extensive than Viz AAA's.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Viz AAA	KardiaAI
Name	Viz AAA	KardiaAI
Company	Viz.ai	AliveCor
Primary Function Focus	AI-powered detection and triage of suspected Abdominal Aortic Aneurysm (AAA) from CT angiography scans.	AI software library for analyzing ambulatory ECG rhythms, detecting various cardiac conditions.
Categories	Cardiology AI, Radiology & Imaging AI, Triage & ER/ICU AI	Cardiology AI
Specialties	Emergency Medicine, Radiology, Vascular Surgery	Cardiology, Emergency Medicine, Internal Medicine
Key Detections/Analysis	AI-powered automatic detection of suspected AAA from CTA scans; Automated triage and prioritization of cases.	Detection of atrial fibrillation, bradycardia, tachycardia, normal sinus rhythm, Sinus Rhythm with Premature Ventricular Contractions (PVCs), Sinus Rhythm with Wide QRS, Sinus Rhythm with Supraventricular Ectopy (SVE).

Videos

Demos, reviews, and walkthroughs featuring Viz AAA and KardiaAI.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do these tools specifically integrate into a physician's existing clinical workflow, and what immediate clinical benefits can be expected?

Viz AAA integrates into existing hospital workflows by providing real-time alerts for suspected Abdominal Aortic Aneurysm (AAA) from CT angiography scans and a HIPAA-compliant communication platform for care teams, accelerating diagnosis and coordination. KardiaAI, as an API library, integrates into existing ECG devices and software, offering AI-powered analysis of ambulatory ECG rhythms to aid in the detection of various cardiac conditions, which can lead to faster diagnoses.

What is the expected depth of integration with existing Electronic Health Record (EHR) systems for each solution?

Viz AAA is designed for integration into existing hospital workflows and can integrate with EHR, PACS, and radiology worklist systems to deliver a unified experience and provide real-time patient data at the point of care. KardiaAI offers an API library for integration into other ECG devices and software, allowing for the incorporation of its AI-powered ECG analysis into various platforms and can automatically pull ECGs into EHR systems like Epic.

Beyond general accuracy claims, what specific performance characteristics or types of conditions can physicians rely on each tool to accurately detect?

Viz AAA is specifically designed for the AI-powered automatic detection and triage of suspected Abdominal Aortic Aneurysm from CT angiography scans, demonstrating high sensitivity (e.g., 86.5%-96%) and specificity (e.g., 95%-98.3%) in studies. KardiaAI provides medical-grade accurate analysis of ambulatory ECG rhythms, detecting conditions such as atrial fibrillation, bradycardia, tachycardia, Sinus Rhythm with Premature Ventricular Contractions (PVCs), Sinus Rhythm with Wide QRS, and Sinus Rhythm with Supraventricular Ectopy (SVE).

What is the anticipated learning curve for physicians and their clinical teams to effectively utilize each tool in their practice?

Viz AAA is designed to integrate into existing hospital workflows with real-time alerts and mobile access to imaging, suggesting a streamlined adoption process focused on interpreting AI-detected findings and coordinating care. For KardiaAI, the learning curve for physicians would primarily involve understanding the output of its AI-powered ECG analysis when integrated into their chosen ECG devices or software platforms, with some Kardia devices requiring minimal self-guided training.

Given their distinct functionalities, how do these tools best align with specific clinical needs and specialties?

Viz AAA is tailored for Emergency Medicine, Radiology, and Vascular Surgery, focusing on accelerating the diagnosis and care coordination for suspected Abdominal Aortic Aneurysm from CT angiography scans. KardiaAI is designed for Cardiology, Emergency Medicine, and Internal Medicine, providing AI-powered analysis of ambulatory ECG rhythms to detect a range of cardiac conditions.

What are the key considerations for successfully implementing and scaling these solutions across multiple hospital sites or clinics?

For Viz AAA, a cloud-based solution integrated into hospital workflows, multi-site rollout would involve standardizing CTA scan processing and care coordination protocols across different facilities. KardiaAI, as an API library, offers flexibility for multi-site deployment by integrating into various ECG devices and software, necessitating consistent integration strategies and interpretation guidelines across diverse clinical environments.

More Comparisons

Assert-IQ vs Rapid Enterprise Platform

AISAP Cardio vs Rapid Enterprise Platform

AngioWaveNet vs Rapid Enterprise Platform

CorVista System with PH Add-On vs Rapid Enterprise Platform

More matchups featuring Viz AAA or KardiaAI

Backers

Who funded each tool's parent company.

Viz AAA

Scale Venture Partners